FDA-approved December 2024), non-alcoholic fatty liver disease (NASH/MASH
Rated 4.83 out of 5 based on 6 customer ratings (6 customer reviews) 35.99 IN STOCK ships today This dual bundle combines GHK-Cu (50mg), a copper-binding peptide explored for tissue repair and skin regeneration, with Epitalon (10mg), a synthetic tetrapeptide studied for its role in circadian regulation and cellular ageing processes
Yu Y, Zhou W, Liang X, Zhou K, Lin X
With peptide therapy, the results build over time, so patience is part of the process
As of 2024, retatrutide has not received a marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA), and no licensed medicinal product containing retatrutide is available in the UK